文献速递腹部MR

钆塞酸二钠增强MRI交互式可解释深度学习模型诊断肝细胞癌:一项回顾性多中心诊断研究

Interactive Explainable Deep Learning Model for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid-enhanced MRI: A Retrospective, Multicenter, Diagnostic Study.
PubMed 文献 · Radiol Imaging Cancer · 2025-01-01

本研究基于钆塞酸二钠增强MRI开发人工智能模型辅助肝细胞癌诊断,纳入839例患者1023个肝局灶性病变,模型在外部测试集AUC为0.97,较LI-RADS LR-5类别显示更高敏感度(91.6% vs 74.8%,P < .001)且特异度相似(90.7% vs 96.0%,P = .22),并提高了两位放射科医师的诊断敏感度。

要点

  • AI模型在外部测试集诊断HCC的AUC为0.97,敏感度91.6%、特异度90.7%。
  • 较LI-RADS LR-5类别,AI模型敏感度更高(91.6% vs 74.8%,P < .001),特异度相似(90.7% vs 96.0%,P = .22)。
  • AI辅助后两位医师识别更多LI-RADS主要特征并更准确分类LR-5病变,敏感度提高且特异度不变。

核心结论

  • AI模型能准确诊断HCC并提高放射科医师的诊断效能。

研究设计与样本

  • 回顾性多中心诊断研究,纳入2015年1月至2021年12月接受钆塞酸二钠增强MRI的839例患者共1023个肝局灶性病变(594个HCC、429个非HCC),恶性病变经病理诊断、良性病变经病理或影像随访确认。

诊断标准与关键数值

  • AI模型在训练集和外部测试集的AUC分别为0.98和0.97;与LI-RADS LR-5类别相比,AI模型敏感度91.6% vs 74.8%(P < .001)、特异度90.7% vs 96.0%(P = .22);AI辅助后 reader 1 敏感度85.7% vs 72.3%(P < .001)、reader 2 敏感度89.1% vs 74.0%(P < .001),特异度 reader 1 93.3%、reader 2 94.7%(两者P > .99)。

临床应用与阅片要点

  • 模型基于每个肝局灶性病变在平扫T1加权、T2加权、动脉期、门静脉期和肝胆期的五个手动标注边界框进行分类,并通过事后算法分析预训练病变分类器的激活模式推断LI-RADS特征的存在,两位放射科医师按LI-RADS标准对外部测试集病变分类。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To develop an artificial intelligence (AI) model based on gadoxetic acid-enhanced MRI to assist radiologists in hepatocellular carcinoma (HCC) diagnosis. Materials and Methods This retrospective study included patients with focal liver lesions (FLLs) who underwent gadoxetic acid-enhanced MRI between January 2015 and December 2021. All hepatic malignancies were diagnosed pathologically, whereas benign lesions were confirmed with pathologic findings or imaging follow-up. Five manually labeled bounding boxes for each FLL obtained from precontrast T1-weighted, T2-weighted, arterial phase, portal venous phase, and hepatobiliary phase images were included. The lesion classifier component, used to distinguish HCC from non-HCC, was trained and externally tested. The feature classifier, based on a post hoc algorithm, inferred the presence of the Liver Imaging Reporting and Data System (LI-RADS) features by analyzing activation patterns of the pretrained lesion classifier. Two radiologists categorized FLLs in the external testing dataset according to LI-RADS criteria. Diagnostic performance of the AI model and the model's impact on reader accuracy were assessed. Results The study included 839 patients (mean age, 51 years ± 12 [SD]; 681 male) with 1023 FLLs (594 HCCs and 429 non-HCCs). The AI model yielded area under the receiver operating characteristic curves of 0.98 and 0.97 in the training set and external testing set, respectively. Compared with LI-RADS category 5, the AI model showed higher sensitivity (91.6% vs 74.8%; P < .001) and similar specificity (90.7% vs 96.0%; P = .22). The two readers identified more LI-RADS major features and more accurately classified category LR-5 lesions when assisted versus unassisted by AI, with higher sensitivities (reader 1, 85.7% vs 72.3%; P < .001; reader 2, 89.1% vs 74.0%; P < .001) and the same specificities (reader 1, 93.3% vs reader 2, 94.7%; P > .99 for both). Conclusion The AI model accurately diagnosed HCC and improved the radiologists' diagnostic performance. Keywords: Artificial Intelligence, Deep Learning, MRI, Hepatocellular Carcinoma Supplemental material is available for this article. © RSNA, 2025 See also commentary by Singh et al in this issue.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Li M, Zhang Z, Chen Z, et al. Interactive Explainable Deep Learning Model for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid-enhanced MRI: A Retrospective, Multicenter, Diagnostic Study. Radiol Imaging Cancer. 2025. PMID: 40445095. doi:10.1148/rycan.240332

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。